Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ammonia + lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Intramuscular, Intraarticular, Topical, Inhalation
01
Overview
**Physician EZ Use Joint Tunnel and Trigger Kit** is a human prescription drug kit marketed by Asclemed USA that combines triamcinolone acetonide injectable suspension, lidocaine hydrochloride injection, a povidone-iodine antiseptic preparation, and an ammonia inhalant. Triamcinolone acetonide is the principal anti-inflammatory component and is a synthetic glucocorticoid receptor agonist; lidocaine provides local anesthesia through voltage-gated sodium-channel blockade, while povidone-iodine provides broad topical antisepsis. The kit is listed in DailyMed as an unapproved drug product; FDA has not found the product safe and effective and has not approved its labeling. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e25cfc22-29ba-473f-88c4-3c88e9f6863b))
- Brand names
- Physician EZ Use Joint Tunnel and Trigger Kit
- Other names
- lidocaine hydrochloride + triamcinolone acetonide + ammonia + povidone-iodine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on ammonia + lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ammonia + lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine.